Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
This study was conducted to evaluate the effects of recombinant probiotic bacteria as a candidate for oral vaccine with the potential of treating allergy to Amaranthus retroflexus pollens. The main gene of this allergen, Ama r 2, was cloned into the food grade plasmid pNZ7025 and then was electrotra...
Main Authors: | Alireza Vasiee, Fereshteh Falah, Mojtaba Sankian, Farideh Tabatabaei-Yazdi, Seyed Ali Mortazavi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2020/2635230 |
Similar Items
-
Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice
by: Ziba Ghasemi, et al.
Published: (2018-06-01) -
Probiotic Lactococcus lactis: A Review
by: Priti Khemariya, et al.
Published: (2017-07-01) -
Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy
by: Dana P. Cook, et al.
Published: (2018-01-01) -
The probiotic effects of a xylanase gene transformed Lactococcus lactis
by: Wei-Chun Hsieh, et al. -
The probiotic effects of a xylanase gene transformed Lactococcus lactis
by: Wei-Chun Hsieh, et al.
Published: (2009)